Medicare Enrolled

Dr. Arnold Greenberg, M.D.

Neurology · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2299 POST ST, San Francisco, CA 94115
4153467505
In practice since 2006 (19 years)
NPI: 1780616177 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Greenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greenberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Greenberg

Dr. Arnold Greenberg is a neurology specialist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Greenberg performed 1,280 Medicare services across 930 unique beneficiaries.

Between the years covered by Open Payments, Dr. Greenberg received a total of $19,138 from 60 pharmaceutical and/or device companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Greenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 27% volume in CA $19,138 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,280
Medicare services
Top 27% in CA for neurology
930
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
778 $82 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
176 $117 $275
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
120 $133 $475
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
68 $97 $365
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
46 $50 $95
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $50 $125
New patient office visit, complex (60-74 min) 23 $190 $550
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
22 $100 $290
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $169 $375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,138
Total received (2018-2024)
Avg $2,734/year across 7 years
Top 16% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,107 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,693
2023
$3,192
2022
$2,713
2021
$3,577
2020
$2,341
2019
$1,969
2018
$2,653

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$383
MDD US Operations, LLC
$334
CATALYST PHARMACEUTICALS, INC.
$294
SK Life Science, Inc.
$251
PFIZER INC.
$246
Lilly USA, LLC
$233
Amneal Pharmaceuticals LLC
$165
Neurelis, Inc.
$111
UCB, Inc.
$110
Lundbeck LLC
$92
SCILEX PHARMACEUTICALS INC.
$80
Eisai Inc.
$72
Neurocrine Biosciences, Inc.
$65
Otsuka America Pharmaceutical, Inc.
$63
Kyowa Kirin, Inc.
$53
ACADIA Pharmaceuticals Inc
$50
ARGENX US, INC.
$27
Janssen Pharmaceuticals, Inc
$27
ABBVIE INC.
$20
E.R. Squibb & Sons, L.L.C.
$18
Top 3 companies account for 37.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$2,339
UCB, Inc.
$1,936
SK Life Science, Inc.
$1,406
Neurocrine Biosciences, Inc.
$1,120
Avanir Pharmaceuticals, Inc.
$923
ABBVIE INC.
$825
Eisai Inc.
$734
Amneal Pharmaceuticals LLC
$688
Amgen Inc.
$668
Sunovion Pharmaceuticals Inc.
$606
Lilly USA, LLC
$596
Biogen, Inc.
$588
Lundbeck LLC
$492
Biohaven Pharmaceuticals, Inc.
$491
PFIZER INC.
$484
MDD US Operations, LLC
$356
CATALYST PHARMACEUTICALS, INC.
$294
Allergan, Inc.
$256
AbbVie Inc.
$224
Catalyst Pharmaceuticals, Inc.
$217
Neurelis, Inc.
$210
Kyowa Kirin, Inc.
$207
Novartis Pharmaceuticals Corporation
$206
Almatica Pharma LLC
$206
EISAI INC.
$205
Otsuka America Pharmaceutical, Inc.
$204
ARBOR PHARMACEUTICALS, INC.
$199
Biohaven Pharmaceutical Holding Company Ltd.
$185
ACADIA Pharmaceuticals Inc
$181
AstraZeneca Pharmaceuticals LP
$177
Alexion Pharmaceuticals, Inc.
$173
Allergan Inc.
$168
Merck Sharp & Dohme Corporation
$141
Acorda Therapeutics, Inc
$132
Supernus Pharmaceuticals, Inc.
$112
Avion Pharmaceuticals
$97
Upsher-Smith Laboratories LLC
$96
SCILEX PHARMACEUTICALS INC.
$94
MITSUBISHI TANABE PHARMA AMERICA, INC.
$83
Sumitomo Pharma America, Inc.
$78
Impax Laboratories, Inc.
$78
Arbor Pharmaceuticals, Inc.
$77
GENZYME CORPORATION
$67
Takeda Pharmaceuticals U.S.A., Inc.
$58
Mitsubishi Tanabe Pharma America, Inc.
$53
AQUESTIVE THERAPEUTICS, INC.
$49
E.R. Squibb & Sons, L.L.C.
$44
INSIGHTEC,INC
$38
Scilex Pharmaceuticals Inc.
$37
BOSTON SCIENTIFIC CORPORATION
$31
Merz Pharmaceuticals, LLC
$30
Ironwood Pharmaceuticals, Inc
$29
ARGENX US, INC.
$27
Janssen Pharmaceuticals, Inc
$27
IDORSIA PHARMACEUTICALS US INC
$22
GE HEALTHCARE
$17
GE Healthcare
$17
Currax Pharmaceuticals LLC
$16
Bausch Health US, LLC
$13
IMPEL PHARMACEUTICALS INC.
$12
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BELSOMRA · BEVESPI AEROSPHERE · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Banzel · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cenobamate · DUOPA · Dayvigo · Dhivy · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · Edarbi · Exablate · FYCOMPA · Fycompa · GEMTESA · GENERAL - DBS · GRALISE · Gocovri · Horizant · INBRIJA · INGREZZA · KISUNLA · KYNMOBI · LYRICA · Leqembi · Linzess · MIGRANAL · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OXTELLAR XR · Ongentys · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SYMPAZAN · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XARELTO · XCOPRI · Xeomin · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in San Francisco?
Compare neurologists in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
245
Per 100K population
29.3
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Greenberg is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Greenberg experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Greenberg performed 778 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greenberg receive payments from pharmaceutical companies?
Yes. Dr. Greenberg received a total of $19,138 from 60 companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greenberg's costs compare to other neurologists in San Francisco?
Dr. Greenberg's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →